Pediatric visceral leishmaniasis in southern France

Pediatric Infectious Disease Journal

Volumn 17, Issue 8, 1998, Pages 701-704

  Minodier, Philippe ^a,c   Piarroux, Renaud ^b,c   Garnier, Jean Marc ^a   Unal, Daniel ^c   Perrimond, Henri ^c   Dumon, Henri ^c  

^a HÔPITAL NORD   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Antimony; Children; Epidemiology; Leishmania infantum; Leishmaniasis; Liposomal amphotericin B.

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; DIAMIDINE DERIVATIVE; MEGLUMINE ANTIMONATE; PENTAMIDINE; PENTAMIDINE ISETHIONATE; STIBOGLUCONATE SODIUM;

ANEMIA; ARTICLE; BONE MARROW BIOPSY; CHILDHOOD DISEASE; COUGHING; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FRANCE; HEMATOMA; HUMAN; HYPERGAMMAGLOBULINEMIA; INFANT; LEISHMANIA INFANTUM; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT FAILURE; VISCERAL LEISHMANIASIS; VOMITING;

EID: 0031839179     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199808000-00008     Document Type: Article

References (26)

1. Hommel M, Paters W, Ranque J, Quilici M, Lanotte G. The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasitol 1978;72:213-8.
2. Gentilini M, Pinon JM, Niel G. Immunoélectrodiffusion sur membrane d'acétate de cellulose: applications en parasitologie: a propos de 600 essais. Bull Soc Pathol Exot 1972;65: 60-6.
3. Mary C, Lamouroux D, Dunan S, Quilici M. Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiologic purposes. Am J Trop Med Hyg 1992;47:764-71.
4. Piarroux R, Fontes M, Perasso R, et al. Phylogenetic relationships between Old World Leishmania strains revealed by analysis of a repetitive DNA sequence. Mol Biochem Parasitol 1995;73:249-52.
5. Piarroux R, Azaiez R, Lossi AM, et al. Isolation and characterization of a repetitive DNA sequence from Leishmania infantum: development of a visceral leishmaniasis polymerase chain reaction. Am J Trop Med Hyg 1993;49:364-9.
6. Piarroux R, Gambarelli F, Dumon H, et al. Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral leishmaniasis in immunocompromised patients. J Clin Microbiol 1994; 32:746-9.
7. Gradoni I, Bryceson A, Desjeux P. Treatment of Mediterranean visceral leishmaniasis. Bull WHO 1995;73:191-7.
8. Giraud P, Bernard R, Vincent P. Note sur l'emploi des médicaments à base d'antimoine: a propos d'un cas de kala-azar traité par le Glucantime. Arch Fr Pediatr 1954;11:659-62.
9. Giraud P, Bernard R, Orsini A, Coignet J. Données nouvelles sur le traitement du kala-azar. Arch Fr Pediatr 1961;18: 1002-13.
10. Dedet JP, Lambert M, Pratlong F. Leishmanioses et infection humaine par le virus de l'immunodéficience humaine. Presse Med 1995;24:1036-40.
11. Rosenthal E, Marty P, Poizot-Martin I, et al. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg 1995;89:159-62.
12. Rodgers MR, Popper SJ, Wirth DF. Amplification of kinetoplast DNA as a tool in the detection and the diagnosis of Leishmania. Exp. Parasitol 1990;71:267-75.
13. Van Yes GJJM, Schooner GJ, Croon NCM, Oblong SB. Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Mol Biochem Parasitol 1992;51:133-42.
14. Milon G, Del Giudice G, Louis JA. Immunobiology of experimental cutaneous leishmaniasis. Parasitol Today 1995;11: 244-7.
15. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
16. + T cells. J Immunol 1987;139:1303-9.
17. Mishra M, Singh MP, Choudhury D, Singh VP, Khan AB. Amphotericin B for second-line treatment of Indian kala-azar. Lancet 1991;337:926.
18. Mishra M, Biswas UK, Jha DN, Khan AB. Amphotericin B versus pentamidine in antimony-unresponsive kala-azar. Lancet 1992;340:1256-7.
19. Mishra M, Biswas UK, Jha AM, Khan AB. Amphotericin B versus sodium stibogluconate in first-line treatment of Indian kala-azar. Lancet 1994;344:1599-1600.
20. Davidson RN, Croft SL, Scott A, Maini M, Moody AH, Bryceson ADM. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet 1991;337:1061-2.
21. Davidson RN, Di Martino L, Gradoni L, et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Q J Med 1994;87:75-81.
22. Di Martino L, Davidson RN, Giacchino R, et al. Treatment of visceral leishmaniasis in children with liposomal amphotericin B. J Pediatr 1997;131:271-7.
23. Squires K, Rosenkaimer F, Sherwood JA, Forni AL, Were JBO, Murray HW. Immunochemotherapie for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma. Am J Trop Med Hyg 1993;48:666-9.
24. Rathore MH, Buksh D, Hassan M. Visceral leishmaniasis in Pakistani children. South Med J 1996;89:491-3.
25. Jeannel D, Tuppin P, Brucker G, Danis M, Gentilini M. Imported and autochthonous kala-azar in France. Br Med J 1991;303:336-8.
26. Thakur CP. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis). Trans R Soc Trop Med Hyg 1984;78:391-8.